Bone Biologics BBLG Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS estimate-$1.23
Next report
Aug 13, 2026 (in a month)EPS estimate-$0.39
Versus estimates
Diluted EPS
Ask the moment Bone Biologics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Bone Biologics report Q3 2025 earnings?
- Bone Biologics (BBLG) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were Bone Biologics's Q3 2025 revenue and EPS?
- Bone Biologics reported diluted EPS of $-0.37 for Q3 2025.
- Did Bone Biologics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-1.23 by $0.86.
- How did Bone Biologics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 97.4% from $-14.22.
- Where can I find Bone Biologics's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001493152-25-023563) directly on SEC EDGAR. The filing index links above go to sec.gov.